redcells diagnostics private limited
Tender Performance & Track Record
Company Overview
Tender Performance
Data for 01 April 2024 to 17 June 2025
Total Bids / Contract Value
Qualified Bids / Q Rate
Total Wins / Win Value
Wins Rate / Q-W Rate
Detailed Performance Analysis
Tender Performance by Ministries
Name
Top Bid Competitors
Companies that frequently compete with you in the same tenders — ranked by their total win value.You applied for 70 bids — VIMEK BIOCONCEPT PRIVATE LIMITED appeared in 35 of them.
REDCELLS DIAGNOSTICS PRIVATE LIMITED
REDCELLS DIAGNOSTICS PRIVATE LIMITED
Financial Details
Registered Office
PLOT NO.D-29/4, TTC INDUSTRIAL AREAMIDC TURBHE, NAVI MUMBAIThane-Thane-Maharashtra-400705-India
Industry Classification
Community, personal & Social Services
Company Type
Market Information
Transform Your Tender Process
Join thousands of businesses winning more tenders
Smart Alerts
Get AI-powered tender recommendations
Market Intel
Track competitor bidding patterns
Email Reports
Weekly detailed analytics reports
Download Hub
Export tender data in bulk format
Smart Tracking
Never miss important deadlines
& Much More...
Discover all premium features with your trial
"TenderAI transformed our bidding process. We've increased our win rate by 40% and saved countless hours."
Historical Performance
7-year trend analysis (2018-2025)
Company Overview (1 Apr 2018-31 Mar 2025))
Total Bids
56
Contract Value
₹1.62 Cr
L1 Bids
10
Recent Win Rate
17.9%
Performance Analytics
REDCELLS DIAGNOSTICS PRIVATE LIMITED: Business Analysis and Strategic Insights
REDCELLS DIAGNOSTICS PRIVATE LIMITED showcases strategic engagement within India's public procurement sector, demonstrated by a portfolio of 55 government tender participations. Despite a total contract value of ₹1,60,75,694.0, the company faces notable challenges reflected in its 18.18% win rate. This report offers a comprehensive business analysis, competitive review, and strategic recommendations to enhance their market positioning and financial performance.
Executive Summary
REDCELLS DIAGNOSTICS PRIVATE LIMITED's performance in government tenders reveals a mixed landscape. While securing 10 L1 positions demonstrates competitive pricing, a low win rate indicates significant room for improvement. The company exhibits financial capacity through consistent EMD payments but needs to refine its bidding strategy to optimize resource allocation and improve overall financial health, currently rated as 'Concerning' with a score of 44.5/100. Strategic recommendations focus on targeted bidding, pre-bid qualification enhancements, and pricing strategy revisions to capitalize on underserved market segments and improve win ratios.
Financial Performance Analysis
This section examines the financial metrics of REDCELLS DIAGNOSTICS PRIVATE LIMITED within the context of government tenders. We analyze yearly performance, bid distribution, and key financial statistics to provide insights into the company's financial health and sustainability.
Key Financial Metrics
- Total Contract Value (FY 2024-25): ₹16,075,694.0